Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study

• Ryo Toyozawa,
• Fumihiro Shoji,
• Takanori Yamashita,
• Fumihiko Kinoshita,
• Shinkichi Takamori,
• Takatoshi Fujishita,
• Kensaku Ito,
• Koji Yamazaki,
• Naoki Nakashima,
• Tatsuro Okamoto

Affiliations

Ryo Toyozawa

Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

Fumihiro Shoji

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Takanori Yamashita

Medical Information Center, Kyushu University, Fukuoka, Japan

Fumihiko Kinoshita

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Shinkichi Takamori

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Takatoshi Fujishita

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Kensaku Ito

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Koji Yamazaki

Department of Thoracic Surgery, National Hospital Organisation Kyushu Medical Center, Fukuoka, Japan

Naoki Nakashima

Medical Information Center, Kyushu University, Fukuoka, Japan

Tatsuro Okamoto

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan